Developer docs
API playgroundTry for free, no card

Search company profiles

WAYS Pharmaceutical Services

Full company profile

uuid000g5ml

Namestring
WAYS Pharmaceutical Services
Legal namestring
WAYS Pharmaceutical Services
Websiteurl
waysps.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

WAYS Pharmaceutical Services is a privately held, founder-led regulatory submission management firm headquartered in Mohnton, Pennsylvania, founded in 2017 by CEO Matt Stroschein. The company specializes in eCTD (Electronic Common Technical Document) submission management for the U.S. Food and Drug Administration and other regulatory authorities, providing end-to-end services including eCTD structure setup, sequence planning, document assembly, validation, and lifecycle management for INDs, NDAs, BLAs, medical device submissions, and advertising/promotional filings. Its core technical focus is on submission architecture decisions — granularity, hyperlinking, bookmarking, and XML backbone construction — areas where practitioner judgment directly affects reviewer efficiency and rejection risk.

The firm's service portfolio centers on Submission Management Services, supplemented by eCTD Strategy consulting and eCTD Training for client teams. WAYS generates revenue through professional services fees on a quote-based, project or retainer basis, with no public pricing. It targets three primary segments: early-stage pharmaceutical companies approaching first INDs, biotechnology companies managing complex multi-sequence lifecycle programs, and medical device companies navigating electronic submission formats. Named enterprise customer Sarepta Therapeutics is publicly endorsed as a Submission Management Partner.

Distribution is sales-led and direct, with practitioner engagement rather than account-management handoffs, and a referral partnership with London-based Green Room Life Sciences supporting European market reach. WAYS pursues a content-driven go-to-market strategy — a branded podcast (WAYS OF WORKING), webinars, white papers, and a blog — to build thought leadership and inbound demand. The firm operates without disclosed external funding, has no subsidiaries, and maintains no patents or trademarks in the available record.

Short descriptiontext

WAYS Pharmaceutical Services is a privately held regulatory submission management firm founded in 2017 and based in Mohnton, Pennsylvania, specializing in eCTD compilation, validation, and lifecycle management for pharmaceutical, biotechnology, and medical device sponsors filing with the FDA.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersState College, United States
HQ citystring
State College
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory submission management, eCTD publishing services, regulatory operations consulting, pharmaceutical regulatory affairs, FDA submission support
Industry4 codes
PRIMARYHLAGAKAC
Regulatory Operations & Publishing (eCTD, RIM, Submission Management)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLACAOAN
Regulatory Submissions & Clinical Content Management (eCTD/Publishing)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Professional, Scientific, and Technical Services54
SIC code2 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
Product category
Regulatory Operations Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Regulatory Submission Management Services
TypeProfessional Services
Description

WAYS generates revenue through professional services fees for regulatory submission management. The company provides end-to-end support for eCTD submissions including structure setup, document compilation, validation, and submission to regulatory authorities. Services are tailored to client needs across INDs, NDAs, BLAs, and lifecycle programs.

waysps.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

WAYS Pharmaceutical Services provides end-to-end regulatory submission management services for life sciences companies, centered on eCTD (Electronic Common Technical Document) compilation, validation, and lifecycle management for FDA and other regulatory authorities. The firm supports sponsors of INDs, NDAs, BLAs, medical device 510(k) submissions, and ongoing compliance maintenance (annual reports, amendments, supplements), with complementary eCTD strategy consulting and training offerings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Prevents technical rejections that could result from late engagement or poor submission structure
+1 more record
Product overview1 text field

WAYS Pharmaceutical Services is a regulatory submission management partner offering a portfolio of services centered on eCTD submissions for life sciences companies. The core offering is Submission Management Services, which provides end-to-end eCTD compilation, validation, and lifecycle management. This is complemented by eCTD Training services (educating client teams on eCTD standards) and eCTD Strategy Services (strategic consulting on submission architecture). The company also provides educational content including the WAYS OF WORKING Podcast and white papers on topics such as finding regulatory submission partners and technical rejection criteria.

Product and service3 records
1Submission Management Services
CategoryRegulatory Operations Services
Description

End-to-end regulatory submission management service providing eCTD compilation, validation, publishing, and lifecycle management for INDs, NDAs, BLAs, medical device submissions, and ongoing maintenance activities (annual reports, amendments, supplements) for pharmaceutical, biotechnology, and medical device sponsors.

2eCTD Training
CategoryTraining and Education Services
Description

Training service that educates client regulatory affairs and product development teams on eCTD standards, submission requirements, and best practices for electronic regulatory submissions.

3eCTD Strategy Services
CategoryRegulatory Consulting Services
Description

Strategic consulting services helping sponsors with eCTD structure decisions, granularity planning, sequence strategy, and regulatory submission architecture to optimize submission outcomes and reviewer experience.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-02
Description

Strategic partnership formalizing two years of cross-client collaborations where WAYS provided submission management and publishing services while TradeCraft delivered CDISC-compliant data packages. The alliance offers comprehensive solutions for small teams needing data expertise alongside efficient submission management, targeting CDISC and eCTD compliance.

2Green Room Life Sciences
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-05-04
Description

Strategic partnership with London-based Green Room Life Sciences to establish local EU market presence as WAYS continues European expansion. Green Room serves as business development and referral channel, providing local expertise in assessing client needs and connecting European pharmaceutical, biotech, and medical device companies to WAYS regulatory submission services.

waysps.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ProPharma provides regulatory affairs, compliance, and quality consulting services to pharma, biotech, and medical device companies, including submission management support. Closely comparable service portfolio and customer base to WAYS.

2Camargo Pharmaceutical Services
TypeDirect peer
Description

Camargo is a regulatory strategy and consulting firm specializing in 505(b)(2) and complex generic submissions for small and mid-size pharma, with deep expertise in FDA regulatory pathways. Highly comparable to WAYS' regulatory operations and submission support model.

TypeBroad incumbent
Description

Parexel is a large global CRO offering regulatory consulting and submission services as part of a broader clinical and biopharmaceutical development portfolio. Represents the broad incumbent against which WAYS competes for regulatory operations work.

TypeDirect peer
Description

Pharmalex provides regulatory affairs and scientific affairs consulting across US and EU, including submission management and lifecycle support. Comparable to WAYS in regulatory operations focus, with broader geographic footprint.

5C3i Solutions (now part of Cencora)
TypeDirect peer
Description

C3i Solutions was a dedicated eCTD submission publishing and regulatory operations services provider serving pharma and biotech sponsors, directly comparable to WAYS' core offering of eCTD compilation, validation, and lifecycle management. Acquired by Cencora, it represents the most direct functional peer.

TypeBroad incumbent
Description

IQVIA is a global life sciences services and analytics firm with regulatory affairs and submission management offerings as part of its integrated CRO platform. A significant broad incumbent in the regulatory operations market.

TypeDirect peer
Description

Halloran is a regulatory, quality, and clinical consulting firm serving emerging biotech and pharma sponsors with submission strategy and execution support. Similar scale, customer profile, and service orientation to WAYS.

TypeBroad incumbent
Description

ICON is a large global CRO with regulatory services including submission publishing and lifecycle management, often packaged with clinical development. A broad incumbent competing for the same enterprise sponsor budgets as WAYS.

TypeOthers
Description

Veeva provides regulatory information management software (Vault RIM) and content management tools that automate eCTD publishing and submission management. Not a direct services competitor, but a technology ecosystem that shapes the addressable market for WAYS' manual services.

10Veristat
TypeEmerging player
Description

Veristat is a mid-size clinical research and regulatory services firm focused on complex therapeutic areas and emerging biotech, with submission and regulatory affairs support. Comparable customer profile and service mix to WAYS, slightly larger.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WAYS Pharmaceutical Services

Regulatory Operations Serviceswaysps.com

WAYS Pharmaceutical Services is a privately held regulatory submission management firm founded in 2017 and based in Mohnton, Pennsylvania, specializing in eCTD compilation, validation, and lifecycle management for pharmaceutical, biotechnology, and medical device sponsors filing with the FDA.

What WAYS Pharmaceutical Services does

WAYS Pharmaceutical Services is a privately held, founder-led regulatory submission management firm headquartered in Mohnton, Pennsylvania, founded in 2017 by CEO Matt Stroschein. The company specializes in eCTD (Electronic Common Technical Document) submission management for the U.S. Food and Drug Administration and other regulatory authorities, providing end-to-end services including eCTD structure setup, sequence planning, document assembly, validation, and lifecycle management for INDs, NDAs, BLAs, medical device submissions, and advertising/promotional filings. Its core technical focus is on submission architecture decisions — granularity, hyperlinking, bookmarking, and XML backbone construction — areas where practitioner judgment directly affects reviewer efficiency and rejection risk.

The firm's service portfolio centers on Submission Management Services, supplemented by eCTD Strategy consulting and eCTD Training for client teams. WAYS generates revenue through professional services fees on a quote-based, project or retainer basis, with no public pricing. It targets three primary segments: early-stage pharmaceutical companies approaching first INDs, biotechnology companies managing complex multi-sequence lifecycle programs, and medical device companies navigating electronic submission formats. Named enterprise customer Sarepta Therapeutics is publicly endorsed as a Submission Management Partner.

Distribution is sales-led and direct, with practitioner engagement rather than account-management handoffs, and a referral partnership with London-based Green Room Life Sciences supporting European market reach. WAYS pursues a content-driven go-to-market strategy — a branded podcast (WAYS OF WORKING), webinars, white papers, and a blog — to build thought leadership and inbound demand. The firm operates without disclosed external funding, has no subsidiaries, and maintains no patents or trademarks in the available record.

WAYS Pharmaceutical Services firmographics

Firmographics
Name
WAYS Pharmaceutical Services
Legal name
WAYS Pharmaceutical Services
Website
https://waysps.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
WAYS Pharmaceutical Services is a privately held regulatory submission management firm founded in 2017 and based in Mohnton, Pennsylvania, specializing in eCTD compilation, validation, and lifecycle management for pharmaceutical, biotechnology, and medical device sponsors filing with the FDA.
Ownership category
akta.pro rank

WAYS Pharmaceutical Services industry classification

Industry
Product category
Regulatory Operations Services
NAICS
Professional, Scientific, and Technical Services (54)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAKAC
Regulatory Operations & Publishing (eCTD, RIM, Submission Management)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLACAOAN
Regulatory Submissions & Clinical Content Management (eCTD/Publishing)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Regulatory submission management
  • ECTD publishing services
  • Regulatory operations consulting
  • Pharmaceutical regulatory affairs
  • FDA submission support

Where WAYS Pharmaceutical Services is headquartered

Location

Headquarters

HQ city
State College
HQ country
United States
HQ region
North America

Offices1 record

Markets served

WAYS Pharmaceutical Services business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Regulatory Submission Management Services: WAYS generates revenue through professional services fees for regulatory submission management. The company provides end-to-end support for eCTD submissions including structure setup, document compilation, validation, and submission to regulatory authorities. Services are tailored to client needs across INDs, NDAs, BLAs, and lifecycle programs.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

WAYS Pharmaceutical Services product offering

Product offering

Core offering

WAYS Pharmaceutical Services provides end-to-end regulatory submission management services for life sciences companies, centered on eCTD (Electronic Common Technical Document) compilation, validation, and lifecycle management for FDA and other regulatory authorities. The firm supports sponsors of INDs, NDAs, BLAs, medical device 510(k) submissions, and ongoing compliance maintenance (annual reports, amendments, supplements), with complementary eCTD strategy consulting and training offerings.

Product overview

WAYS Pharmaceutical Services is a regulatory submission management partner offering a portfolio of services centered on eCTD submissions for life sciences companies. The core offering is Submission Management Services, which provides end-to-end eCTD compilation, validation, and lifecycle management. This is complemented by eCTD Training services (educating client teams on eCTD standards) and eCTD Strategy Services (strategic consulting on submission architecture). The company also provides educational content including the WAYS OF WORKING Podcast and white papers on topics such as finding regulatory submission partners and technical rejection criteria.

Differentiator

Problem solved

Functional benefit

Products and services

  • Submission Management Services End-to-end regulatory submission management service providing eCTD compilation, validation, publishing, and lifecycle management for INDs, NDAs, BLAs, medical device submissions, and ongoing maintenance activities (annual reports, amendments, supplements) for pharmaceutical, biotechnology, and medical device sponsors.
  • eCTD Training Training service that educates client regulatory affairs and product development teams on eCTD standards, submission requirements, and best practices for electronic regulatory submissions.
  • eCTD Strategy Services Strategic consulting services helping sponsors with eCTD structure decisions, granularity planning, sequence strategy, and regulatory submission architecture to optimize submission outcomes and reviewer experience.

Quantifiable outcome

  • Prevents technical rejections that could result from late engagement or poor submission structure
  • +1 more outcomes

Companies that use WAYS Pharmaceutical Services

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

WAYS Pharmaceutical Services technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

WAYS Pharmaceutical Services partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • TradeCraft Clinical ResearchcoreStrategic or Co-development Partner · 2 June 2021Strategic partnership formalizing two years of cross-client collaborations where WAYS provided submission management and publishing services while TradeCraft delivered CDISC-compliant data packages. The alliance offers comprehensive solutions for small teams needing data expertise alongside efficient submission management, targeting CDISC and eCTD compliance.
  • Green Room Life SciencescoreChannel Partner/ Reseller/ Distributor · 4 May 2021Strategic partnership with London-based Green Room Life Sciences to establish local EU market presence as WAYS continues European expansion. Green Room serves as business development and referral channel, providing local expertise in assessing client needs and connecting European pharmaceutical, biotech, and medical device companies to WAYS regulatory submission services.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

WAYS Pharmaceutical Services competitors and assessment

Company assessment

Direct peers

  • ProPharma Group: ProPharma provides regulatory affairs, compliance, and quality consulting services to pharma, biotech, and medical device companies, including submission management support. Closely comparable service portfolio and customer base to WAYS.
  • Camargo Pharmaceutical Services: Camargo is a regulatory strategy and consulting firm specializing in 505(b)(2) and complex generic submissions for small and mid-size pharma, with deep expertise in FDA regulatory pathways. Highly comparable to WAYS' regulatory operations and submission support model.
  • Pharmalex: Pharmalex provides regulatory affairs and scientific affairs consulting across US and EU, including submission management and lifecycle support. Comparable to WAYS in regulatory operations focus, with broader geographic footprint.
  • C3i Solutions (now part of Cencora): C3i Solutions was a dedicated eCTD submission publishing and regulatory operations services provider serving pharma and biotech sponsors, directly comparable to WAYS' core offering of eCTD compilation, validation, and lifecycle management. Acquired by Cencora, it represents the most direct functional peer.
  • Halloran Consulting Group: Halloran is a regulatory, quality, and clinical consulting firm serving emerging biotech and pharma sponsors with submission strategy and execution support. Similar scale, customer profile, and service orientation to WAYS.

Broad incumbents

  • Parexel International: Parexel is a large global CRO offering regulatory consulting and submission services as part of a broader clinical and biopharmaceutical development portfolio. Represents the broad incumbent against which WAYS competes for regulatory operations work.
  • IQVIA: IQVIA is a global life sciences services and analytics firm with regulatory affairs and submission management offerings as part of its integrated CRO platform. A significant broad incumbent in the regulatory operations market.
  • ICON plc: ICON is a large global CRO with regulatory services including submission publishing and lifecycle management, often packaged with clinical development. A broad incumbent competing for the same enterprise sponsor budgets as WAYS.

Others

  • Veeva Systems: Veeva provides regulatory information management software (Vault RIM) and content management tools that automate eCTD publishing and submission management. Not a direct services competitor, but a technology ecosystem that shapes the addressable market for WAYS' manual services.

Emerging players

  • Veristat: Veristat is a mid-size clinical research and regulatory services firm focused on complex therapeutic areas and emerging biotech, with submission and regulatory affairs support. Comparable customer profile and service mix to WAYS, slightly larger.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

WAYS Pharmaceutical Services social profiles

Digital presence

WAYS Pharmaceutical Services financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WAYS Pharmaceutical Services leadership team

Management profile

Number of profiles

Profiles4 records

WAYS Pharmaceutical Services funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WAYS Pharmaceutical Services M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WAYS Pharmaceutical Services

What does WAYS Pharmaceutical Services do?

WAYS Pharmaceutical Services provides end-to-end regulatory submission management services for life sciences companies, centered on eCTD (Electronic Common Technical Document) compilation, validation, and lifecycle management for FDA and other regulatory authorities. The firm supports sponsors of INDs, NDAs, BLAs, medical device 510(k) submissions, and ongoing compliance maintenance (annual reports, amendments, supplements), with complementary eCTD strategy consulting and training offerings.

Is WAYS Pharmaceutical Services a public or private company?

WAYS Pharmaceutical Services is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was WAYS Pharmaceutical Services founded?

WAYS Pharmaceutical Services was founded in 2017. It employs 11 to 50 people.

Where is WAYS Pharmaceutical Services based?

WAYS Pharmaceutical Services is headquartered in State College, United States, in the North America region.

How does WAYS Pharmaceutical Services make money?

One revenue line is on record: regulatory Submission Management Services.

Who are WAYS Pharmaceutical Services's main competitors?

Direct peers on record are ProPharma Group, Camargo Pharmaceutical Services, Pharmalex, C3i Solutions (now part of Cencora) and Halloran Consulting Group. Broad incumbents are Parexel International, IQVIA and ICON plc. Veeva Systems is listed as an others. Veristat is listed as an emerging player.

Does WAYS Pharmaceutical Services have an API?

No public API is recorded for WAYS Pharmaceutical Services.

What industry is WAYS Pharmaceutical Services in?

WAYS Pharmaceutical Services's product category is Regulatory Operations Services. Its primary akta.pro industry code is HLAGAKAC, Regulatory Operations & Publishing (eCTD, RIM, Submission Management), with a secondary code of HLACAOAN, Regulatory Submissions & Clinical Content Management (eCTD/Publishing). Its NAICS code is 54 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales